Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The reference to 'AstraZeneca UK Limited' has been removed, while 'AstraZeneca' remains mentioned on the page.
    Difference
    0.1%
    Check dated 2025-03-03T23:26:38.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to reflect that the study is now active and not recruiting, with a total of 30 locations listed. Additionally, several past dates and contact information have been removed.
    Difference
    6%
    Check dated 2025-02-24T20:34:54.000Z thumbnail image
  5. Check
    29 days ago
    No Change Detected
  6. Check
    36 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:39:35.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T06:30:37.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T21:38:07.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    The website has updated the intervention type and contact information for the Principal Investigator, while also removing the previous version details.
    Difference
    3%
    Check dated 2025-01-12T17:16:05.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.